Last reviewed · How we verify
NCT06256809: QQA-FPD-PMML
Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study
trial in Oral Leukoplakia in 160 participants. Status unknown.
15 March 2024
Quick facts
| Lead sponsor | King Khalid University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 160 |
| Start date | 29 February 2024 |
| Primary completion | 15 March 2024 |
| Estimated completion | 30 March 2024 |
Conditions studied
- Oral Leukoplakia — all drugs for Oral Leukoplakia →
Sponsor
King Khalid University
Who can join
Eligibility, any sex, with Oral Leukoplakia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aims: To evaluate the qualitative and quantitative parameters of finger and palmar dermatoglyphic patterns in patients with oral premalignant and malignant lesions OBJECTIVES: 1. To record and study the palmar and fingerprint patterns in patients with oral premalignant and malignant lesions 2. To assess the variations in patterns of dermatoglyphic features between cases and controls and to observe the significant result. 3\. To evaluate which dermatoglyphic pattern is predominant among patients with premalignant and malignant lesions. Materials and METHODS: Fingerprints and palm prints were studied in 160 patients, who were randomly divided into four groups: A. 40 patients with a history of areca nut /tobacco intake with the occurrence of the premalignant lesion (B) 40 patients with a history of areca nut /tobacco intake with the occurrence of Oral Squamous Cell Carcinoma. (C) As healthy controls, 40 patients with tobacco/areca nut chewing habits, without any evidence of oral lesions (D) 40 patients without any habit, and without any oral lesions. Dermatoglyphic patterns were recorded and analyzed in the four groups using the standard ink method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06256809
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oral Leukoplakia
Currently open trials in the same condition.
- NCT07331935 — Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment · NA · recruiting
- NCT07149220 — Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults With Premalignant Oral Lesions. · Phase 1 · recruiting
- NCT05727761 — Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia · Phase 2 · recruiting
- NCT06321003 — SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography · recruiting
- NCT03975322 — Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore · recruiting
Other King Khalid University trials
Trials by the same sponsor.
- NCT06774196 — Integrating Behavioral Therapy in the Management of Temporomandibular Disorders: A Comprehensive Evaluation Using DC/TMD · NA · completed
- NCT06948682 — Exploring the Relationship Between Occlusion and Degenerative TMJ Disorders: A Comparative Clinical Study · NA · completed
- NCT07396610 — Effect of Diode Laser and Bioactive Glass on Dentinal Hypersensitivity · NA · completed
- NCT06758479 — Differential Impact of TMJ Disc Displacement and Muscle Disorders on Pain, Function, and Quality of Life in TMD Patients · completed
- NCT06280651 — Dietary Impacts on Oral Health in Autistic Children: A Cross-Sectional Analysis · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06256809 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Khalid University
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06256809.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing